Higher frequency of secretor phenotype in O blood group – its benefits in prevention and/or treatment of some diseases
Open Access
- 1 November 2010
- journal article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. 5, 901-5
Abstract
Peer reviewed article authored by (Mohamad Salih Jaff). Read article or submit your manuscript for publishing.Keywords
This publication has 36 references indexed in Scilit:
- Pancreatic Cancer Risk and ABO Blood Group Alleles: Results from the Pancreatic Cancer Cohort ConsortiumCancer Research, 2010
- JAA-F11Expert Opinion on Biological Therapy, 2007
- Blood groups and disease: A historical perspectiveTransfusion Medicine Reviews, 2000
- Lewis phenotypes, insulin resistance, and risk of ischaemic heart disease.Heart, 1994
- Ovarian cancer and ABO blood groups.Journal of Epidemiology and Community Health, 1993
- ABO blood groups in hematologic malignanciesCancer Genetics and Cytogenetics, 1991
- The role of the Thomsen-Friedenreich antigen as a tumor-associated molecule.Environmental Health Perspectives, 1990
- Investigation of Lewis Phenotypes in Polynesians: Evidence of a Weak Secretor PhenotypeVox Sanguinis, 1990
- On the Mechanism behind the Association between ABO Blood Groups and Gastric CarcinomaHuman Heredity, 1987
- ABH‐Blood‐Group Antigens and Glycolipids of Human SalivaEuropean Journal of Biochemistry, 1978